Relationship between homocysteine and cardiovascular diseases in older adults

Journal of the American Geriatrics Society

Volumn 52, Issue 11, 2004, Pages 1955-1956

  Kuo, Hsu Ko ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; META ANALYSIS; NOTE; PREDICTION; RISK ASSESSMENT; STROKE; SYSTEMATIC REVIEW; ARTICLE; BLOOD; CEREBROVASCULAR ACCIDENT; HEART MUSCLE ISCHEMIA; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 16544391642     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52526.x     Document Type: Note

References (18)

1. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol (1969);56:111-128.
2. Booth GL, Wang EE. Preventive health care, 2000 update. Screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. Can Med Assoc J 2000;163:21-29.
3. Selhub J, Jacques PK, Wilson PW et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
4. Christen WG, Ajani UA, Glynn RJ et al. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 2000;160:422-434.
5. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
6. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
7. Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality. The Hoorn Study. Kidney Int 2002;62:1402-1407.
8. Loria CM, Ingram DD, Feldman JJ et al. Serum folate and cardiovascular disease mortality among U.S. men and women. Arch Intern Med 2000;160:3258-3262.
9. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
10. Bjelland I, Tell GS, Vollset S et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C - > T polymorphism in anxiety and depression. The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618-626.
11. Kado DM, Bucur A, Selhub J et al. Homocysteine levels and decline in physical function. Macarthur Studies of Successful Aging. Am J Med 2002;113:537-542.
12. Saltzman E, Mason JB, Jacques P et al. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ 1998;316:894-898.
13. Jacques PF, Selhub J, Bostom AG et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454.
14. Joshipura KJ, Hu FB, Manson JE et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001;134:1106-1114.
15. Rimm EB, Willett WC, Hu FB et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-364.
16. Schnyder G, Roffi M, Pin R et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593-1600.
17. Toole JF. Vitamin intervention for stroke prevention. J Neurol Sci 2002;203-204:121-124.
18. The VITATOPS (Vitamins to Prevent Stroke Trial). Rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis 2002;13:120-126.